Literature DB >> 24284535

The tubercular disease in immigrants without documents: new diagnostic settings adopted in Milan, Italy.

P Olivani1, L Codecasa, A Colucci, S Della Valle, L Mai, M Marceca, D Panizzut, E Sachsel.   

Abstract

The tubercular disease (TB) is "the disease of poverty and people in need", spread in the poorest countries and among the less wealthy people of the western world (immigrants). In Italy the health authority has recently defined precise diagnostic and therapeutic patterns for TB. The social and health Association Naga in Milan with the Regional Reference Centre for TB, designed a screening system. In Naga's surgery all the undocumented immigrants, coming to Italy from countries with high TB incidence (> 100/100000) and high immigration rates, are screened by a questionnaire created by the Swiss Lung League; the suspect cases are sent to a designed centre for a second level of investigation. The use of this form allows to set a first selection based on the patients' anamnestic history, thus avoiding the intradermal reaction that, due to its low selectivity, could cause a 4 times higher crowding of the designed secondary centers.

Entities:  

Mesh:

Year:  2013        PMID: 24284535     DOI: 10.7416/ai.2013.1949

Source DB:  PubMed          Journal:  Ann Ig        ISSN: 1120-9135


  2 in total

1.  Active Tuberculosis Case Finding Interventions Among Immigrants, Refugees and Asylum Seekers in Italy.

Authors:  Monica Sañé Schepisi; Gina Gualano; Pierluca Piselli; Marta Mazza; Donatella D'Angelo; Francesca Fasciani; Alberto Barbieri; Giorgia Rocca; Filippo Gnolfo; Piefranco Olivani; Maurizio Ferrarese; Luigi Ruffo Codecasa; Fabrizio Palmieri; Enrico Girardi
Journal:  Infect Dis Rep       Date:  2016-06-24

2.  Lessons learnt from TB screening in closed immigration centres in Italy.

Authors:  Anna Crepet; Ernestina Repetto; Ahmad Al Rousan; Monica Sané Schepisi; Enrico Girardi; Tullio Prestileo; Luigi Codecasa; Silvia Garelli; Salvatore Corrao; Giuseppe Ippolito; Tom Decroo; Barbara Maccagno
Journal:  Int Health       Date:  2016-05-20       Impact factor: 2.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.